School of Studies in Biotechnology, Jiwaji University, Gwalior, Madhya Pradesh, India.
Pest Manag Sci. 2014 Apr;70(4):517-23. doi: 10.1002/ps.3676. Epub 2013 Nov 19.
India, the seventh largest country in the world, has diverse geographical and climatic regions with vast rural and peri-urban areas. Many are experiencing an escalation in the spread and intensity of numerous human diseases transmitted by insects. Classically, the management of these vector-borne diseases is underpinned by either chemical insecticides and/or environmental management targeted at the vector. However, these methods or their present implementation do not offer acceptable levels of control, and more effective and sustainable options are now available. Genetic strategies for the prevention of arbovirus transmission are most advanced for dengue and chikungunya, targeting their primary vector, Aedes aegypti. The national burden in terms of morbidity and mortality as a direct consequence of dengue virus in India is considered to be the largest worldwide, over 4 times that of any other country. Presently, new genetic technologies are undergoing field evaluation of their biosafety and efficacy in several countries. This paper discusses the merits of these approaches and argues for fair and transparent appraisal in India as a matter of urgency. Identification of any associated risks and their appropriate mitigation are fundamental to that process.
印度是世界第七大国,拥有多样化的地理和气候区域,以及广阔的农村和城郊地区。许多地区正在经历昆虫传播的多种人类疾病的传播和强度的升级。传统上,这些虫媒传染病的管理是基于化学杀虫剂和/或针对媒介的环境管理。然而,这些方法或其目前的实施方式并没有提供可接受的控制水平,现在有更有效和可持续的选择。预防虫媒病毒传播的遗传策略在登革热和基孔肯雅热方面最为先进,针对其主要媒介埃及伊蚊。印度因登革热病毒而直接导致的发病率和死亡率的国家负担被认为是全球最大的,是任何其他国家的 4 倍以上。目前,新的遗传技术正在几个国家进行田间评估,以评估其生物安全性和有效性。本文讨论了这些方法的优点,并呼吁印度作为紧急事项进行公平和透明的评估。确定任何相关风险及其适当缓解是该过程的基础。